- Home
- HROW vs NAC Comparison
HROW vs NAC Comparison
Compare HROW & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- NAC
- Stock Information
- Founded
- HROW 1998
- NAC 1998
- Country
- HROW United States
- NAC France
- Employees
- HROW N/A
- NAC N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- NAC Investment Managers
- Sector
- HROW Health Care
- NAC Finance
- Exchange
- HROW Nasdaq
- NAC Nasdaq
- Market Cap
- HROW 1.4B
- NAC 1.6B
- IPO Year
- HROW N/A
- NAC N/A
- Fundamental
- Price
- HROW $36.81
- NAC $11.82
- Analyst Decision
- HROW Strong Buy
- NAC
- Analyst Count
- HROW 7
- NAC 0
- Target Price
- HROW $68.50
- NAC N/A
- AVG Volume (30 Days)
- HROW 804.0K
- NAC 307.3K
- Earning Date
- HROW 11-10-2025
- NAC 01-01-0001
- Dividend Yield
- HROW N/A
- NAC 4.33%
- EPS Growth
- HROW N/A
- NAC N/A
- EPS
- HROW N/A
- NAC N/A
- Revenue
- HROW $227,661,000.00
- NAC N/A
- Revenue This Year
- HROW $43.92
- NAC N/A
- Revenue Next Year
- HROW $41.22
- NAC N/A
- P/E Ratio
- HROW N/A
- NAC N/A
- Revenue Growth
- HROW 47.69
- NAC N/A
- 52 Week Low
- HROW $20.85
- NAC $9.32
- 52 Week High
- HROW $54.19
- NAC $11.21
- Technical
- Relative Strength Index (RSI)
- HROW 38.13
- NAC 68.05
- Support Level
- HROW $36.20
- NAC $11.77
- Resistance Level
- HROW $39.77
- NAC $11.89
- Average True Range (ATR)
- HROW 1.89
- NAC 0.08
- MACD
- HROW -0.40
- NAC 0.00
- Stochastic Oscillator
- HROW 9.98
- NAC 75.86
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.